Supernus Pharmaceuticals, Inc. (SUPN): Shareholders' Equity
$1.06B
As of 2025-12-31
$1.03B
As of 2026-06-30
+6.2%
3-year compound annual growth
+7.3%
5-year compound annual growth
+28.3%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.06B | +2.5% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $1.04B | +12.4% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $921.52M | +4.0% | 2026-03-02, Balance as of period end |
| 2022-12-31 | $886.20M | +8.6% | 2025-02-25, Balance as of period end |
| 2021-12-31 | $815.85M | +9.5% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $744.86M | +25.1% | 2023-03-09, Balance as of period end |
| 2019-12-31 | $595.43M | +31.4% | 2022-04-13, Balance as of period end |
| 2018-12-31 | $453.02M | +69.4% | 2021-03-08, Balance as of period end |
| 2017-12-31 | $267.48M | +39.5% | 2020-02-28, Balance as of period end |
| 2016-12-31 | $191.75M | +117.9% | 2019-03-01, Balance as of period end |
| 2015-12-31 | $88.01M | +116.2% | 2018-03-01, Balance as of period end |
| 2014-12-31 | $40.70M | +21.6% | 2017-03-16, Balance as of period end |
| 2013-12-31 | $33.46M | -41.9% | 2017-01-20, Balance as of period end |
| 2012-12-31 | $57.57M | +509.7% | 2015-03-12, Balance as of period end |
| 2011-12-31 | $9.44M | n/m | 2014-03-21, Balance as of period end |
| 2010-12-31 | -$44.32M | n/a | 2013-03-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $1.06B | +2.5% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $788.80M | +7.7% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $693.11M | -11.0% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $522.60M | +8.2% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $647.80M | -4.7% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $567.61M | +29.5% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | -$80.00M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $301.68M | +31.8% |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $88.30M | +54.9% |
Compare SUPN, AMPH, PCRX, EBS side by side · Screen every company in Pharmaceutical Preparations ↗